Positive autocontrol minor incompatibility in pure red cell aplasia patient: A case report

Main Article Content

Ni Putu Yunita Puspitra Sari https://orcid.org/0000-0002-9105-3049
Raehana Samad
Mansyur Arif

Keywords

crossmatch, incompatibility, pure red cell aplasia

Abstract

Introduction: Pure red cell aplasia (PRCA) is a syndrome of normochromic normocytic anemia with severe reticulocytopenia and marked reduction or absence of erythroid precursors in the bone marrow. The serum of PRCA patients often contains immunoglobulin G (IgG) antibodies that suppress the growth of erythroid progenitor cells in vitro. This report focused on the diagnosis and management of a PRCA case.


Case Description: A 5-year-old boy presented with complaints of pallor for two days and generalized weakness for five days. Medical history included a tuberculosis infection, for which he underwent treatment with anti-tuberculosis drugs, including rifampicin and isoniazid. He had a history of recurrent pallor and multiple hospitalizations due to decreased hemoglobin levels, requiring routine blood transfusions since 2018 at Wahidin Sudirohusodo Hospital. Laboratory investigations revealed normochromic normocytic anemia, severe reticulocytopenia, and bone marrow aspiration findings of normocellular marrow with significantly reduced erythropoiesis activity. Crossmatch testing showed minor incompatibility (1+) and autocontrol positivity (1+), with the degree of minor incompatibility matching the positive autocontrol results, indicative of erythrocytes coated with autoantibodies. Monoclonal Direct Coombs Test (DCT) findings included IgG positivity (1+) and C3d negativity. Packed red cell (PRC) transfusion was successfully administered under medical supervision.


Conclusion: This case highlights a 5-year-old boy diagnosed with pure red cell aplasia based on clinical presentation, physical examination findings, and laboratory investigations. The patient's treatment involved blood transfusion, which was administered with appropriate precautions to manage the underlying anemia effectively.

Abstract 91 | pdf Downloads 69

References

1. Means RTJ. Pure red cell aplasia. Blood. 2016 Nov;128(21):2504–9. Available from : DOI: 10.1182/blood-2016-05-717140.
2. Arbiv OA, Cuvelier G, Klaassen RJ, Fernandez C V, Robitaille N, Steele M, et al. Molecular analysis and genotype-phenotype correlation of Diamond-Blackfan anemia. Clin Genet. 2018 Feb;93(2):320–8. Available from : DOI: 10.1111/cge.13158.
3. Bergmann AK, Campagna DR, McLoughlin EM, Agarwal S, Fleming MD, Bottomley SS, et al. Systematic molecular genetic analysis of congenital sideroblastic anemia: evidence for genetic heterogeneity and identification of novel mutations. Pediatr Blood Cancer. 2010 Feb;54(2):273–8. Available from : DOI: 10.1002/pbc.22244.
4. Cerchione C, Catalano L, Cerciello G, Avilia S, Picardi M, Risitano AM, et al. Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA). Vol. 94, Annals of hematology. Germany; 2015. p. 531–4. Available from : DOI: 10.1007/s00277-014-2192-z.
5. Keithi-Reddy SR, Kandasamy S, Singh AK. Pure red cell aplasia due to follow-on epoetin. Kidney Int. 2008 Dec;74(12):1617–22. Available from : DOI: 10.1038/ki.2008.230.
6. Yang XY, Chen L, Gu JN, Zeng CJ, Pan DM. Linezolid-Induced Pure Red Cell Aplasia: A Case Report. Vol. 15, Infection and drug resistance. New Zealand; 2022. p. 3847–56. Available from : DOI: 10.2147/IDR.S362358.
7. Balasubramanian SK, Sadaps M, Thota S, Aly M, Przychodzen BP, Hirsch CM, et al. Rational management approach to pure red cell aplasia. Haematologica. 2018 Feb;103(2):221–30. Available from : DOI: 10.3324/haematol.2017.175810.
8. Gurnari C, Maciejewski JP. How I manage acquired pure red cell aplasia in adults. Blood. 2021 Apr;137(15):2001–9. Available from : DOI: 10.1182/blood.2021010898.
9. Widaya K and Pardjono E. Immune Hemolytic Anemia. In Setiati S, Alwi I, Sudoyo AW, Simadibrata M, Stiyohadi B, Syam AF. Textbook o. Jakarta: Interna Publishing; 2014. 2607–13 p.
10. Cenariu D, Iluta S, Zimta AA, Petrushev B, Qian L, Dirzu N, et al. Extramedullary Hematopoiesis of the Liver and Spleen. J Clin Med. 2021 Dec;10(24). Available from : DOI: 10.3390/jcm10245831.
11. Mulyantari, NK. Yasa I. Pretransfusion Laboratory Update. Udayana University Press. Bali; 2016.